GRIFOLS SA INH. A EO-,25/ ES0171996087 /
2024-05-03 11:05:29 AM | Chg. +0.3140 | Volume | Bid5:36:45 PM | Ask5:36:45 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.8960EUR | +3.66% | 850 Turnover: 7,530.6000 |
-Bid Size: - | -Ask Size: - | 7.27 bill.EUR | - | 98.78 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...